Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAMONA: Nivolumab and Ipilimumab in Elderly ESCC
NCT03416244Phase 2Completed
- Sponsor
- AIO-Studien
- Start
- Feb 2018
- Primary completion
- Nov 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab, ipilimumab in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by AIO-Studien. Started Feb 2018; status: completed.
02
Drugs
nivolumabipilimumab
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03416244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03416244.